USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2023-11-02 обновлены отчеты компании IMGN: 2023-Q32022-Q42022-Q3
ImmunoGen logo
ImmunoGen IMGN
$ 31.23 0.0%

ImmunoGen Мультипликаторы 2011-2024 | IMGN

Мультипликаторы по годам ImmunoGen

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-4.6 -8.4 -28.3 -6.9 -4.2 -8.5 -1.7 -25.4 -13.3 -21.8 -16.4 -16.0

P/S

9.3 16.7 9.5 8.8 13.4 7.1 4.0 18.0 15.9 44.8 73.7 48.3

EPS

-0.9 -0.7 -0.2 -0.7 -1.2 -1.0 -1.8 -0.7 -0.8 -0.9 -0.9 -0.8

EV (Enterprise Value)

935 млн 886 млн 1.23 млрд 857 млн 736 млн 861 млн 451 млн 1.57 млрд 897 млн 1.49 млрд 1.14 млрд 819 млн

EBITDA per Share

-0.86 -0.6 -0.12 -0.45 -1.07 -0.533 -1.38 -0.569 -0.783 -0.813 -0.893 -0.802

EV/EBITDA

-6.1 -40.7 -8.2 -3.0 -10.5 -0.8 -25.8 -12.1 -20.4 -15.2 -13.4

PEG

-0.06 -0.14 -2.79 0.17 -0.19 -1.04 -0.01 1.75 2.89 2.59 -1.4 6.96

P/B

6.5 3.6 14.0 -9.5 65.0 -45.6 -2.9 43.9 12.5 13.1 14.4 6.7

P/CF

-4.4 -6.9 -16.0 -7.9 -4.2 125.0 -1.8 -24.6 -15.4 -24.8 -32.4 -93.1

ROE %

-143.06 -42.79 -49.54 136.80 -1538.85 536.53 175.95 -173.03 -94.27 -59.76 -87.40 -41.63

ROA %

-63.89 -26.50 -12.50 -44.26 -57.16 -32.58 -50.44 -19.35 -43.17 -34.09 -40.66 -26.78

ROCE %

-141.76 -38.41 -24.99 -44.81 -70.20 -24.36 -55.39 -19.59 -49.65 -37.55 -44.65 -29.64

Current Ratio

1.8 2.6 1.3 2.7 3.9 5.0 4.1 8.2 7.1 10.5 10.2 13.8

DSO

- - - 120.9 82.4 16.5 13.9 24.8 19.7 21.8 29.6 88.3

DIO

- - - - - 2.7 2.2 9.6 10.1 2.9 - -

DPO

- - - 31.7 23.8 22.4 28.4 26.6 16.4 18.9 - -

Операционный цикл

- - - 120.9 82.4 19.2 16.2 34.3 29.7 24.7 - -

Финансовый цикл

- - - 89.2 58.6 -3.1 -12.2 7.8 13.3 5.9 - -

Все данные представлены в валюте USD

Мультипликаторы поквартально ImmunoGen

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

0.1 -0.02 -0.16 - -0.31 -0.24 -0.1 - -0.18 -0.15 -0.17 - -0.13 -0.14 -0.17 0.03 -0.15 -0.29 -0.3 -0.28 -0.32 -0.31 -0.3 -0.11 -0.61 -0.1 -0.2 -0.39 -0.51 -0.53 -0.51 -0.38 -0.39 -0.38 -0.39 0.16 -0.26 0.16 -0.26 0.04 -0.13 0.04 -0.13 -0.29 -0.3 -0.29 -0.3 -0.17 -0.26 -0.17 -0.26

EBITDA per Share

- - -0.16 - -0.3 -0.24 -0.09 - -0.16 -0.14 -0.14 - -0.09 -0.1 -0.14 0.06 -0.1 -0.26 -0.27 -0.27 -0.27 -0.25 -0.26 -0.07 -0.29 -0.03 -0.13 -0.33 -0.43 -0.43 -0.43 -0.32 -0.32 -0.3 -0.32 0.16 -0.24 0.19 -0.24 0.04 -0.12 0.07 -0.12 -0.29 -0.29 -0.26 -0.31 -0.17 -0.24 -0.14 -0.27

ROE %

-66.90 -116.05 -140.01 -114.25 -87.80 -92.55 -112.63 -140.93 -94.47 -71.01 8.93 80.15 38.78 92.33 50.97 9.60 -365.04 -774.57 -1149.21 -1523.84 -1069.58 -152.09 278.42 756.31 705.35 198.08 178.58 120.44 297.23 -22.67 -139.52 -239.90 -421.43 -168.58 -63.75 -31.61 -46.28 -17.89 -32.77 -12.55 -33.42 -40.03 -72.24 -93.06 -86.18 -85.90 -65.94 -49.83 -15.74 -9.11 -13.92

ROA %

-27.99 -53.40 -57.82 -48.61 -38.77 -24.66 -34.86 -39.69 -23.78 -17.50 1.54 20.22 13.42 10.48 3.69 -3.11 -19.30 -24.21 -40.41 -56.60 -46.90 -65.34 -54.19 -45.93 -58.65 -48.56 -68.65 -74.19 -70.23 -59.55 -46.34 -41.80 -17.98 -21.74 -3.60 -10.19 -18.92 -8.96 -15.42 -7.20 -19.65 -24.01 -39.32 -48.04 -43.60 -43.41 -35.74 -30.72 -9.79 -5.86 -8.95

ROCE %

-74.50 -122.62 -146.20 -75.39 -119.80 -120.71 -136.24 -115.10 -133.78 -108.05 -88.57 -65.76 -76.92 -34.64 39.79 121.09 -236.17 -674.75 -1081.88 -1471.46 -1048.08 -459.21 -77.32 329.60 293.38 144.90 142.73 117.86 268.27 -3.59 -110.51 -239.20 -390.56 -181.27 -82.66 -30.10 -45.01 -17.35 -32.47 -12.83 -33.74 -40.30 -72.59 -93.38 -86.44 -86.11 -66.03 -49.84 -15.73 -9.13 -13.91

Current Ratio

3.2 3.2 1.7 1.8 2.0 - 2.8 2.6 1.4 1.3 1.4 1.3 1.3 1.3 1.3 0.8 0.8 0.8 0.8 1.0 1.0 1.0 1.0 0.9 0.9 0.9 0.9 0.6 0.6 0.6 0.8 0.9 1.0 1.1 1.1 2.5 1.7 1.8 1.8 2.8 2.5 2.3 2.3 2.4 2.6 1.9 1.9 2.2 2.6 2.8 2.8

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD